John Overdeck’s Alder Biopharmaceuticals ALDR Stock Holding History

John Overdeck’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-58,385	Closed	-$1.1M	–	4177
2019 Q3	$1.1M	Sell	58,385 -156,801	-73%	-$1.79M	﹤0.01%	1904
2019 Q2	$2.53M	Buy	215,186 +194,505	+941%	+$2.35M	0.01%	1284
2019 Q1	$282K	Sell	20,681 -35,617	-63%	-$461K	﹤0.01%	2641
2018 Q4	$577K	Buy	+56,298	New	+$721K	﹤0.01%	2012
2015 Q3	–	Sell	-62,209	Closed	-$3.29M	–	2959
2015 Q2	$3.29M	Buy	+62,209	New	+$2.26M	0.02%	922

John Overdeck's ALDR Position: Q4 2019 in Review

John Overdeck sold out of Alder Biopharmaceuticals (ALDR) in Q4 2019, closing a stake of 58,385 shares — an estimated $1.1M sold.

John Overdeck first reported a position in ALDR in Q2 2015 and held it in 5 quarters. The position peaked at $3.29M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALDR as of Q4 2019.

John Overdeck reported no remaining Alder Biopharmaceuticals position as of Q4 2019 after selling out during the quarter.
John Overdeck sold 58,385 Alder Biopharmaceuticals shares in Q4 2019, an estimated $1.1M.
John Overdeck first reported a position in Alder Biopharmaceuticals in Q2 2015 and held it in 5 quarters.
John Overdeck's Alder Biopharmaceuticals position peaked at $3.29M in Q2 2015.
0 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2019.

Based on Two Sigma Investments's 13F filing for Q4 2019, filed 14 Feb 2020.